Crestline Management, LP Dynavax Technologies Corp Transaction History
Crestline Management, LP
- $1.88 Billion
- Q3 2024
A detailed history of Crestline Management, LP transactions in Dynavax Technologies Corp stock. As of the latest transaction made, Crestline Management, LP holds 253,770 shares of DVAX stock, worth $3.29 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
253,770Holding current value
$3.29 Million% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding DVAX
# of Institutions
273Shares Held
129MCall Options Held
451KPut Options Held
203K-
Black Rock Inc. New York, NY21.9MShares$284 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT12.5MShares$163 Million5.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.22MShares$120 Million0.0% of portfolio
-
Kynam Capital Management, LP Princeton, NJ8.33MShares$108 Million7.62% of portfolio
-
State Street Corp Boston, MA7.69MShares$99.8 Million0.0% of portfolio
About DYNAVAX TECHNOLOGIES CORP
- Ticker DVAX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 126,474,000
- Market Cap $1.64B
- Description
- Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...